Franklin Todd Watanabe's Insider Trades & SAST Disclosures
Franklin Todd Watanabe's most recent trade in Arcutis Biotherapeutics Inc was a trade of 1,200 Common Stock done at an average price of $17.6 . Disclosure was reported to the exchange on March 17, 2025.
Add Superstar Alert
Note
This is a custom search result for pattern Franklin Todd Watanabe.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
Showing you 100 results sorted by most recent dates.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
|
Arcutis Biotherapeutics Inc
|
Todd Franklin Watanabe | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 17.61 per share. | 17 Mar 2025 | 1,200 | 928,914 (2%) | 0% | 17.6 | 21,137 | Common Stock |
|
Arcutis Biotherapeutics Inc
|
Todd Franklin Watanabe | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 396,000 | 396,000 | - | - | Stock Option (right to buy) | |
|
Arcutis Biotherapeutics Inc
|
Todd Franklin Watanabe | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 151,000 | 955,129 (2%) | 0% | 0 | Common Stock | |
|
Arcutis Biotherapeutics Inc
|
Todd Franklin Watanabe | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 13.03 per share. | 28 Feb 2025 | 20,880 | 934,249 (2%) | 0% | 13.0 | 272,089 | Common Stock |
|
Arcutis Biotherapeutics Inc
|
Todd Franklin Watanabe | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 13.28 per share. | 28 Feb 2025 | 4,135 | 930,114 (2%) | 0% | 13.3 | 54,930 | Common Stock |
|
Arcutis Biotherapeutics Inc
|
Todd Franklin Watanabe | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 12.70 per share. | 03 Feb 2025 | 19,301 | 804,129 (2%) | 0% | 12.7 | 245,123 | Common Stock |
|
Arcutis Biotherapeutics Inc
|
Todd Franklin Watanabe | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 15.17 per share. | 20 Dec 2024 | 15,000 | 823,430 (2%) | 0% | 15.2 | 227,567 | Common Stock |
|
Arcutis Biotherapeutics Inc
|
Todd Franklin Watanabe | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 8.68 per share. | 04 Nov 2024 | 13,871 | 832,392 (2%) | 0% | 8.7 | 120,459 | Common Stock |
|
Arcutis Biotherapeutics Inc
|
Todd Franklin Watanabe | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 9.02 per share. | 02 Aug 2024 | 14,487 | 846,263 (2%) | 0% | 9.0 | 130,648 | Common Stock |
|
Arcutis Biotherapeutics Inc
|
Todd Franklin Watanabe | Director, See Remarks | Purchase of securities on an exchange or from another person at price $ 1.69 per share. | 31 May 2024 | 4,000 | 836,392 (2%) | 0% | 1.7 | 6,768 | Common Stock |
|
Arcutis Biotherapeutics Inc
|
Todd Franklin Watanabe | Director, See Remarks | Purchase of securities on an exchange or from another person at price $ 7.11 per share. | 31 May 2024 | 2,038 | 838,430 (2%) | 0% | 7.1 | 14,482 | Common Stock |
|
Arcutis Biotherapeutics Inc
|
Todd Franklin Watanabe | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 8.74 per share. | 02 May 2024 | 13,783 | 860,750 (2%) | 0% | 8.7 | 120,433 | Common Stock |
|
Arcutis Biotherapeutics Inc
|
Todd Franklin Watanabe | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 11.12 per share. | 04 Mar 2024 | 14,903 | 874,533 (2%) | 0% | 11.1 | 165,739 | Common Stock |
|
Arcutis Biotherapeutics Inc
|
Watanabe Franklin Todd | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 10.60 per share. | 28 Feb 2024 | 2,465 | 889,436 (2%) | 0% | 10.6 | 26,129 | Common Stock |
|
Arcutis Biotherapeutics Inc
|
Franklin Watanabe Todd | Director, See Remarks | Sale or transfer of securities back to the company at price $ 0.00 per share. | 13 Feb 2024 | 232,200 | 0 | - | - | Stock Option (right to buy) | |
|
Arcutis Biotherapeutics Inc
|
Watanabe Franklin Todd | Director, See Remarks | Sale or transfer of securities back to the company at price $ 0.00 per share. | 13 Feb 2024 | 188,100 | 0 | - | - | Stock Option (right to buy) | |
|
Arcutis Biotherapeutics Inc
|
Watanabe Franklin Todd | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2024 | 116,100 | 891,901 (2%) | 0% | - | Common Stock | |
|
Arcutis Biotherapeutics Inc
|
Franklin Watanabe Todd | Director, See Remarks | Sale or transfer of securities back to the company at price $ 0.00 per share. | 13 Feb 2024 | 99,200 | 0 | - | - | Stock Option (right to buy) | |
|
Arcutis Biotherapeutics Inc
|
Watanabe Franklin Todd | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2024 | 94,050 | 775,801 (2%) | 0% | - | Common Stock | |
|
Arcutis Biotherapeutics Inc
|
Todd Watanabe Franklin | Director, See Remarks | Sale or transfer of securities back to the company at price $ 0.00 per share. | 13 Feb 2024 | 65,000 | 0 | - | - | Stock Option (right to buy) | |
|
Arcutis Biotherapeutics Inc
|
Franklin Watanabe Todd | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2024 | 33,066 | 681,751 (1%) | 0% | - | Common Stock | |
|
Arcutis Biotherapeutics Inc
|
Todd Franklin Watanabe | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2024 | 21,666 | 648,685 (1%) | 0% | - | Common Stock | |
|
Arcutis Biotherapeutics Inc
|
Todd Watanabe Franklin | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 410,000 | 410,000 | - | - | Stock Option (right to buy) | |
|
Arcutis Biotherapeutics Inc
|
Watanabe Todd Franklin | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 125,000 | 627,019 (1%) | 0% | 0 | Common Stock | |
|
Arcutis Biotherapeutics Inc
|
Franklin Todd Watanabe | Director, See Remarks | Gift of securities by or to the insider at price $ 0.00 per share. | 20 Dec 2023 | 6,563 | 24,413 (0%) | 0% | 0 | Common Stock | |
|
Arcutis Biotherapeutics Inc
|
Watanabe Todd Franklin | Director, See Remarks | Gift of securities by or to the insider at price $ 0.00 per share. | 20 Dec 2023 | 6,563 | 508,582 (1%) | 0% | 0 | Common Stock | |
|
Arcutis Biotherapeutics Inc
|
Franklin Todd Watanabe | Director, See Remarks | Gift of securities by or to the insider at price $ 0.00 per share. | 20 Dec 2023 | 6,563 | 24,413 (0%) | 0% | 0 | Common Stock | |
|
Arcutis Biotherapeutics Inc
|
Watanabe Franklin Todd | Director, See Remarks | Gift of securities by or to the insider at price $ 0.00 per share. | 20 Dec 2023 | 6,563 | 502,019 (1%) | 0% | 0 | Common Stock | |
|
Arcutis Biotherapeutics Inc
|
Todd Franklin Watanabe | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 15.26 per share. | 06 Mar 2023 | 2,435 | 366,657 (0%) | 0% | 15.3 | 37,167 | Common Stock |
|
Arcutis Biotherapeutics Inc
|
Todd Franklin Watanabe | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2023 | 232,000 | 232,000 | - | - | Stock Option (right to buy) | |
|
Arcutis Biotherapeutics Inc
|
Todd Franklin Watanabe | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2023 | 87,500 | 456,592 (1%) | 0% | 0 | Common Stock | |
|
Arcutis Biotherapeutics Inc
|
Todd Franklin Watanabe | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 15.82 per share. | 28 Feb 2023 | 5,403 | 369,161 (0%) | 0% | 15.8 | 85,466 | Common Stock |
|
Arcutis Biotherapeutics Inc
|
Todd Franklin Watanabe | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 16.17 per share. | 28 Feb 2023 | 2,343 | 374,564 (0%) | 0% | 16.2 | 37,878 | Common Stock |
|
Arcutis Biotherapeutics Inc
|
Todd Franklin Watanabe | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 16.52 per share. | 28 Feb 2023 | 69 | 369,092 (0%) | 0% | 16.5 | 1,140 | Common Stock |
|
Arcutis Biotherapeutics Inc
|
Todd Franklin Watanabe | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 17.00 per share. | 13 Feb 2023 | 441 | 377,466 (0%) | 0% | 17 | 7,497 | Common Stock |
|
Arcutis Biotherapeutics Inc
|
Todd Franklin Watanabe | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 17.02 per share. | 13 Feb 2023 | 417 | 377,007 (0%) | 0% | 17.0 | 7,097 | Common Stock |
|
Arcutis Biotherapeutics Inc
|
Todd Franklin Watanabe | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 17.03 per share. | 13 Feb 2023 | 100 | 376,907 (0%) | 0% | 17.0 | 1,703 | Common Stock |
|
Arcutis Biotherapeutics Inc
|
Todd Franklin Watanabe | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 17.00 per share. | 13 Feb 2023 | 42 | 377,424 (0%) | 0% | 17 | 714 | Common Stock |
|
Arcutis Biotherapeutics Inc
|
Todd Franklin Watanabe | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 17.00 per share. | 01 Feb 2023 | 618 | 378,289 (0%) | 0% | 17.0 | 10,509 | Common Stock |
|
Arcutis Biotherapeutics Inc
|
Todd Franklin Watanabe | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 17.00 per share. | 01 Feb 2023 | 382 | 377,907 (0%) | 0% | 17 | 6,494 | Common Stock |
|
Arcutis Biotherapeutics Inc
|
Todd Franklin Watanabe | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 18.00 per share. | 07 Nov 2022 | 1,000 | 379,907 (0%) | 0% | 18.0 | 18,004 | Common Stock |
|
Arcutis Biotherapeutics Inc
|
Todd Franklin Watanabe | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 19.51 per share. | 07 Oct 2022 | 1,000 | 380,907 (1%) | 0% | 19.5 | 19,510 | Common Stock |
|
Arcutis Biotherapeutics Inc
|
Todd Franklin Watanabe | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 07 Sep 2022 | 268,964 | 382,907 (1%) | 0% | 0 | Common Stock | |
|
Arcutis Biotherapeutics Inc
|
Todd Franklin Watanabe | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 21.51 per share. | 07 Sep 2022 | 1,000 | 381,907 (1%) | 0% | 21.5 | 21,510 | Common Stock |
|
Arcutis Biotherapeutics Inc
|
Todd Franklin Watanabe | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 24.74 per share. | 05 Aug 2022 | 2,500 | 651,871 (1%) | 0% | 24.7 | 61,858 | Common Stock |
|
Arcutis Biotherapeutics Inc
|
Todd Franklin Watanabe | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Aug 2022 | 2,500 | 109,348 | - | - | Stock Option (Right to Buy) | |
|
Arcutis Biotherapeutics Inc
|
Todd Franklin Watanabe | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.68 per share. | 05 Aug 2022 | 2,500 | 654,371 (1%) | 0% | 1.7 | 4,202 | Common Stock |
|
Arcutis Biotherapeutics Inc
|
Todd Franklin Watanabe | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jul 2022 | 7,087 | 111,848 | - | - | Stock Option (Right to Buy) | |
|
Arcutis Biotherapeutics Inc
|
Todd Franklin Watanabe | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 25.41 per share. | 08 Jul 2022 | 7,087 | 651,871 (1%) | 0% | 25.4 | 180,112 | Common Stock |
|
Arcutis Biotherapeutics Inc
|
Todd Franklin Watanabe | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.68 per share. | 08 Jul 2022 | 7,087 | 658,958 (1%) | 0% | 1.7 | 11,910 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges